Accellta
Haifa, Israel· Est.
Scalable, carrier‑free stem cell culture platform for biopharma and food‑tech.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Scalable, carrier‑free stem cell culture platform for biopharma and food‑tech.
Regenerative MedicineCell TherapyFood Technology
Technology Platform
Proprietary 3D suspension culture system that enables large‑scale, carrier‑free expansion of pluripotent stem cells in a defined, GMP‑compatible environment.
Opportunities
Expanding CDMO services for cell‑therapy manufacturers and scaling cultivated food ingredient production to meet growing demand for sustainable proteins.
Risk Factors
Adoption speed of the carrier‑free platform, competition from established contract manufacturers, and regulatory uncertainty for cultivated food products.
Competitive Landscape
Competes with large CDMO providers like Lonza and Thermo Fisher; differentiation stems from its non‑GMO, carrier‑free suspension technology that reduces cost and simplifies scale‑up.